調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018

セルベースアッセイ（Cell-based Assay）のグローバル市場動向（～2018）

◆タイトル：Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018
◆商品コード：Markets-BT-2486
◆調査・発行会社：MarketsandMarkets
◆発行日：2014年5月
◆ページ数：254
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User（～5名）USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate licence （社内共有可） USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"セルベースアッセイ（Cell-based Assay）のグローバル市場動向（～2018）"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場環境分析、市場の動態、製品別分析、用途別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

The market for cell-based assays is driven by the preference over biochemical assays and animal models and the emergent 3D cell-based assay techniques in cell-based assays
There has been a substantial rise in the costs to develop a new drug in recent years. This is specially observed when a new compound enters animal testing. The use of animals in experimentation is becoming dearer, due to limitations such as high costs involved in breeding and acquisition of animals, due to the complexity of procedures involved in the in vivo testing, and several other ethical issues and legal issues associated with it. Moreover the traditional biochemical assays also posses many limitations. To counteract these issues there has been a paradigm shift towards the use of cell-based assays.
The consumables formed the largest product segment of the total cell-based assays market in 2013, which includes assay kits and reagents, microplates and cell lines. The largest contribution of consumables was attributed to the large volume market of reagents and assay kits; where most of the innovation is taking place. Drug discovery was the most prominent application of cell-based assays. Within drug discovery, lead identification and optimization accounted for the largest share in 2013. With respect to end users, the pharmaceutical and biotechnology companies commanded the largest share in 2013. These industries are focusing on screening extensive libraries of compounds that could become leads for potential drug candidates. The screening process has helped the pharmaceutical companies to run more cost and time efficient methods.
For accurate results, the low cost label-free technology in cell based assays has emerged as a momentous technology that has been driving the growth of cell-based assay market. With the advancement in the cell stem cell culture, induced pluripotent stem cells will be emerging in near future. With the increasing demand of emergent 3D cell-based assay, it is estimated to be the fastest growing technology in the next five years.
North America accounted for the largest share of the global cell-based assay market in 2013. The presence of a large number of market players along with government funding for drug discovery and increasing number of public-private partnerships are the factors driving the North American cell-based assay market. Countries such as India and China serve as new revenue pockets for the cell-based assay market. Healthcare reforms, government initiatives, growing awareness and increasing investments in drug discovery are encouraging the rising acceptance and adoption of the cell-based assay technology in these regions. The emerging countries in Asia such as China and India will register high growth in the coming years; this can be attributed to the low development costs offered by these nations. Moreover, clinical research organizations are growing at fastest rate and more inclined to set their pace in these nations.
The grey areas while estimating the market size was the overlapping nature of the products and technology while segregating them based on evaluation of endpoints involved. As there is a thin line between products and technology used, both were included while estimating the patient monitoring market.
From an insight perspective, this research report focuses on the qualitative data, market size, share, growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of cell-based assay market, high-growth regions, and the initiatives of respective governments.
The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the cell-based assay market, product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data From Secondary Sources
1.6.4 Key Data Points From Primary Sources
1.6.5 Assumptions

2 Executive Summary (Page No. – 32)

3 Premium Insights (Page No. – 36)
3.1 Global Cell-Based Assays Market
3.2 Market Dynamics
3.3 Snapshot of the Market
3.4 Consumables & Instruments Market For Cell-Based Assays
3.5 Geographic Analysis
3.6 Application Market
3.7 End User Market

4 Market Overview (Page No. – 43)
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Significant Advantages of Cell-Based Assays Over Conventional Techniques Provide Ideal Solution For A Range of Research & Commercial Applications
4.2.1.2 Government Funding and Public-Private Partnerships Support Cell-Based Research Activities
4.2.1.3 Drug Discovery, Major Driver For Cell-Based Assays Market
4.2.1.4 Implementation of Hts and Automation Techniques Accelerates the Drug Discovery Process
4.2.2 Restraints
4.2.2.1 Shortage of Skilled Experts & High Instrument Costs Have A Negative Impact
4.2.2.2 Skepticism About Long-Term Benefits of Reporter Assay Kits May Affect their Adoption
4.2.2.3 Intellectual Property Rights Issues Restrict Innovations in the Market
4.2.3 Opportunities
4.2.3.1 Asian Market Presents High-Growth Opportunities
4.2.3.2 Need to De-Risk Early-Phase Drug Discovery Reinforces Cell-Based toxicity Screening
4.2.3.3 Developments in High-Content Screening and Software to Transform Cell-Based Screening
4.2.4 Trends
4.2.4.1 Use of Stem Cells & 3d Culture Defines the Future of the Market
4.2.4.2 Assay Development and Assay Screening Services Are the Most Prominent Trend
4.2.4.3 Label-Free Technologies Are Set to Transform the Market
4.3 Burning Issues & Challenges
4.3.1 Consistent Supply of Cells Creates A Bottleneck
4.3.2 New Technologies Call For Assay Optimization
4.4 Winning Imperatives
4.4.1 Assay Multiplexing
4.4.2 Assay Miniaturization & Microfluidics
4.5 Porter’s Five Forces Analysis
4.5.1 Threat From New Entrants
4.5.2 Threat From Substitutes
4.5.3 Competitors Rivalry
4.5.4 Bargaining Power of Suppliers
4.5.5 Bargaining Power of Buyers
4.6 Market Share Analysis

5 Cell-Based Assays Market, By Product (Page No. – 63)
5.1 Introduction
5.2 Consumables
5.2.1 Reagents & Assay Kits
5.2.1.1 Cell Growth Assays
5.2.1.2 Cell Death Assays
5.2.1.3 Second Messenger Assays
5.2.1.4 Reporter Gene Assays
5.2.1.5 Other Assays
5.2.2 Microplates
5.2.3 Cell Lines
5.2.3.1 Immortalized Cell Lines
5.2.3.2 Primary Cell Lines
5.2.3.3 Stem Cell Lines
5.2.4 Other Consumables
5.3 Instruments
5.3.1 Detection & Screening Instruments
5.3.1.1 Microplate Readers
5.3.1.2 Flow Cytometers
5.3.1.3 Fluorescent Microscopes
5.3.1.4 High Content Screening Instruments
5.3.1.5 Label-Free Detection Instruments
5.3.1.6 Other Detection and Screening Instruments
5.3.2 Automation & High Throughput Screening Instruments
5.4 Software
5.5 Services

6 Cell-Based Assays Market, By Application (Page No. – 109)
6.1 Introduction
6.2 Basic Research
6.3 Drug Discovery
6.3.1 Target Identification and Validation
6.3.2 Lead Identification & Optimization
6.4 Absorption, Distribution, Metabolism & Excretion (Adme) Studies
6.5 Predictive Toxicology
6.6 Other Applications

7 Cell-Based Assays Market, By End User (Page No. – 126)
7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.3 Academic & Government Institutions
7.4 Contract Research Organizations (CRO)
7.5 Other End Users (Hospitals/Clinical Labs, Food/ Agriculture Industries & Environmental Labs)

8 Cell-Based Assays, By Geography (Page No. – 136)
8.1 Introduction
8.2 North America
8.2.1 Emphasis on Technological Advancements Drives the U.S. Market
8.2.2 Research Networks in Canada to Boost the Market
8.3 Europe
8.3.1 Decline in Venture Capitalist Investments in Early Drug Discovery Shifts the Burden to Public Funding
8.3.2 Public-Private Partnerships to Accelerate Drug Discovery Process in European Union
8.4 Asia
8.4.1 Stem Cell Research in Japan
8.4.2 Drug Discovery Outsourcing Fuels the Market Growth in China and India
8.5 ROW

9 Competitive Landscape (Page No. – 179)
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Collaborations & Partnerships
9.4 Acquisitions
9.5 Others

10 Company Profiles (Page No. – 188)
10.1 Becton, Dickinson and Company
10.2 Cell Signaling Technology
10.3 Cisbio Bioassays (Argos Soditic)
10.4 Danaher Corporation
10.5 Discoverx
10.6 EMD Millipore (A Subsidiary of Merck Kgaa)
10.7 Ge Healthcare (Subsidiary of General Electric Company)
10.8 Life Technologies (Thermo Fisher Scientific)
10.9 Perkinelmer, Inc.
10.10 Promega Corporation

*Details on Business Overview, Financials, Product & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (88)

Table 1 Global Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 2 Global Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 3 Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 4 Global Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 5 Consumables Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 6 Global Reagents & Assay Kits Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 7 Reagents & Assay Kits Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 8 Cell Growth Assays Market, By Geography, 2011–2018 ($Million)
Table 9 Cell Death Assays Market, By Geography, 2011–2018 ($Million)
Table 10 Second Messenger Assays Market, By Geography, 2011–2018 ($Million)
Table 11 Reporter Gene Assays Market, By Geography, 2011–2018 ($Million)
Table 12 Other Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 13 Microplates Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 14 Global Cell Lines Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 15 Cell Lines Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 16 Other Consumables Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 17 Global Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 18 Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 19 Global Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 20 Detection & Screening Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 21 Microplate Readers Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 22 Flow Cytometers Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 23 Fluorescent Microscopes Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 24 High Content Screening Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 25 Label-Free Detection Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 26 Other Detection & Screening Instruments For Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 27 Automation & Hts Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 28 Software Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 29 Services Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 30 Global Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 31 Cell-Based Assays Market For Basic Research, By Geography, 2011–2018 ($Million)
Table 32 Cell-Based Assays Market For Drug Discovery, By Geography, 2011–2018 ($Million)
Table 33 Global Cell-Based Assays Market For Drug Discovery, By Type, 2011–2018 ($Million)
Table 34 Cell-Based Assays Market For Target Identification & Validation, By Geography, 2011–2018 ($Million)
Table 35 Cell-Based Assays Market For Lead Identification & Optimization, By Geography, 2011–2018 ($Million)
Table 36 Cell-Based Assays Market For Adme Studies, By Geography, 2011–2018 ($Million)
Table 37 Cell-Based Assays Market For Predictive Toxicology, By Geography, 2011–2018 ($Million)
Table 38 Cell-Based Assays Market For Other Applications, By Geography, 2011–2018 ($Million)
Table 39 Global Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 40 Cell-Based Assays Market For Pharmaceutical & Biotechnology Companies, By Geography, 2011–2018 ($Million)
Table 41 Cell-Based Assays Market For Academic & Government Institutions, By Geography, 2011–2018 ($Million)
Table 42 Cell-Based Assays Market For Contract Research Organizations, By Geography, 2011–2018 ($Million)
Table 43 Cell-Based Assays Market For Other End Users, By Geography, 2011–2018 ($Million)
Table 44 Global Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 45 North America: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 46 North America: Consumables Market For Cell-Based Assays, By Product, 2011-2018 ($Million)
Table 47 North America: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 48 North America: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 49 North America: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 50 North America: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 51 North America: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 52 North America: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 53 Europe: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 54 Europe: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 55 Europe: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 56 Europe: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 57 Europe: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 58 Europe: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 59 Europe: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 60 Europe: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 61 Asia: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 62 Asia: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 63 Asia: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 64 Asia: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 65 Asia: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 66 Asia: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 67 Asia: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 68 Asia: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 69 ROW: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 70 ROW: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 71 ROW: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 72 ROW: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 73 ROW: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 74 ROW: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 75 ROW: Cell-Based Assays Market, By Type, 2011–2018 ($Million)
Table 76 ROW: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 77 New Product Launches, 2012–2014
Table 78 Agreements, Partnerships & Collaborations, 2011–2013
Table 79 Acquistions, 2011–2014
Table 80 Other Developments, 2012–2013
Table 81 Becton, Dickinson and Company, By Segment, 2011–2013 ($Million)
Table 82 Danaher Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 83 Merck Kgaa: Total Revenue, 2011–2013 ($Million)
Table 84 General Electric: Total Revenue, By Segment, 2011–2013 ($Million)
Table 85 Life Technologies: Total Revenue, 2010–2012 ($Million)
Table 86 Life Technologies: Total Revenue, By Segment, 2010–2012 ($Million)
Table 87 Life Technologies: Total Revenue, By Geography, 2010–2012 ($Million)
Table 88 Perkinelmer: Total Revenue, By Segment, 2011–2013 ($Million)

List of Figures (20)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology & Triangulation
Figure 3 Data Triangulation Methodology
Figure 4 Global Cell-Based Assays Market, By Application, 2013 & 2018
Figure 5 Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Figure 6 Global Cell-Based Assays Market, 2013 ($Million)
Figure 7 Global Cell-Based Assays Market Dynamics
Figure 8 Global Cell-Based Assays Market Snapshot, 2013 ($Million)
Figure 9 Consumables & Instruments Market For Cell-Based Assays, 2013 ($Million)
Figure 10 Cell-Based Assays Market, Geographic Analysis, By Product, 2013 ($Million)
Figure 11 Opportunity Matrix: Global Cell-Based Assays Market By Application, 2013
Figure 12 Global Cell-Based Assays Market, By End User, 2013 Vs 2018 ($Million)
Figure 13 Cell-Based Assays Market: Porter's Five Forces Analysis
Figure 14 Cell-Based Assays, Revenue Market Share Analysis, By Key Players, 2013
Figure 15 Global Cell-Based Assays Market, By Product, 2013 ($Million)
Figure 16 Global Cell-Based Assays Market, By Application, 2013 ($Million)
Figure 17 Cell-Based Assay Applications in Drug Discovery Stages
Figure 18 Global Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Figure 19 Cell-Based Assays Product Lifecycle, By Geography
Figure 20 Key Growth Strategies, Cell-Based Assays Market, 2011–2014

【レポートのキーワード】

セルベースアッセイ、細胞アッセイ、培養細胞

★調査レポート[セルベースアッセイ（Cell-based Assay）のグローバル市場動向（～2018）] ( Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018 / Markets-BT-2486) 販売に関する免責事項
[セルベースアッセイ（Cell-based Assay）のグローバル市場動向（～2018）] ( Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018 / Markets-BT-2486) についてEメールでお問い合わせ
◆関連調査資料◆
  • 細胞アッセイの世界市場予測（～2022年）：試薬、アッセイキット、マイクロプレート、細胞株、サービス
    MAM-BT2486 / MarketsandMarkets / 2017年7月6日 / 当調査レポートでは、細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4%. A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market. The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global...
  • 細胞生存率アッセイの世界市場予測（～2023年）：MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計
    BT-6577 / MarketsandMarkets / 2018年9月5日 / MarketsandMarketsが発行した当調査レポートでは、細胞生存率アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（MTTアッセイ、XTTアッセイ、カルセイン、レサズリン、フローサイトメトリー、分光光度計）分析、細胞タイプ（ヒト、動物、微生物）分析、用途（基礎研究、幹細胞、創薬・開発）分析、細胞生存率アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell viability assays market is projected to reach USD 4.16 billion by 2023 from USD 2.78 billion in 2018, at a CAGR of 8.4%. Factors contributing to the growth of this market include the rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research, rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics. The report analyzes the global cell viability assays market by product, cell type, application, end user, and region. On the basis of product, the consumables segment is expected to account for the largest...
  • マルチプレックスアッセイの世界市場予測（～2023年）
    BT-4473 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、装置）別分析、種類別分析、技術別分析、用途（研究開発、診断）別分析、マルチプレックスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the multiplex assays...
  • ハイスループットスクリーニング（HTS）の世界市場予測（～2023年）：細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス
    BT2220 / MarketsandMarkets / 2018年4月24日 / 当調査レポートでは、ハイスループットスクリーニング（HTS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術（細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス）別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニング（HTS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global high-throughput screening (HTS) market is projected to reach USD 21.69 Billion by 2023 from USD 14.87 Billion in 2018, at a CAGR of 7.8%. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments. The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS...
  • 幹細胞アッセイの世界市場予測（～2023年）
    MAM-BT-4628 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、細胞タイプ別分析、製品別分析、用途別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments. The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the...
  • 神経科学用抗体＆アッセイの世界市場予測（～2023年）
    BT6283 / MarketsandMarkets / 2018年5月16日 / MarketsandMarketsが発行した当調査レポートでは、神経科学用抗体＆アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（試薬、装置）別分析、技術別分析、用途別分析、需要先別分析、神経科学用抗体＆アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. This report segments the neuroscience antibodies and assays market into product, technology, application, end user, and region. Based on product, the neuroscience antibodies and assays market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to...
  • 薬物スクリーニング検査の世界市場予測（～2022年）：免疫測定アナライザー、クロマトグラフィー、飲酒検知器、迅速検査デバイス、アッセイキット
    MD-3239 / MarketsandMarkets / 2018年1月15日 / MarketsandMarketsが発行した当調査レポートでは、薬物スクリーニング検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、サービス別分析、サンプル種類別分析、需要先別分析、薬物スクリーニング検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global drug screening market projected to grow at a CAGR of 10.2% during the forecast period”The drug screening market is expected to reach USD 8.63 billion million by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆